Forte Biosciences, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementForte Biosciences, Inc. • April 1st, 2022 • Pharmaceutical preparations • New York
Company FiledApril 1st, 2022 Industry JurisdictionForte Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Agent”) as follows: